The Longevity Stack

Two compounded protocols. One nightly routine.

Compounded NAD+ and compounded sermorelin, prescribed online under a single physician-led plan. Cellular co-factor support paired with the body’s own growth-hormone axis — for sleep depth, daily recovery, and lean-mass preservation as you age.

$349/month · cancel anytime · HSA/FSA eligible · $999 every 3 months Save $48 LegitScript Certified Healthcare Merchant LegitScript CertifiedHealthcare Merchant · verified by independent audit
Prescribed by U.S.-licensed providers 503A pharmacy partners · USP <797> sterility Ships in 2-3 business days Cancel or pause anytime

One protocol, one shipment

Two compounded medications, one physician, one monthly price.

0

Compounded protocols under one physician-led plan

0

Monthly shipment. Discreet, temperature-controlled where needed

0

U.S. states where the protocol is available

0

Week recheck recommended with baseline labs

What’s in the stack

Two compounded preparations. One nightly window.

Each medication is prepared by an FDA-registered 503A pharmacy and dispensed under your provider’s prescription. Compounded preparations are not FDA-approved.

OPTML compounded NAD+ injection vial
Cellular co-factor

Compounded NAD+

Subcutaneous nicotinamide adenine dinucleotide. NAD+ is the co-factor that hundreds of cellular enzymes rely on to convert nutrients to energy and to drive DNA repair pathways. Levels decline with age in published research.

Form
Subcutaneous injection
Cadence
Weekly
OPTML compounded sermorelin injection vial
GH-axis support

Compounded Sermorelin

A GHRH analog that signals the pituitary to release pulses of the body’s own growth hormone. Used in clinical contexts for documented age-related GH-axis decline. Dosed at bedtime to match the body’s natural release window.

Form
Subcutaneous injection
Cadence
Nightly at bedtime

Who this is for

Built for adults who’ve already done the basics.

The Longevity Stack is reviewed and prescribed by a U.S.-licensed physician based on your intake, history, and (in most cases) baseline labs. It’s not for everyone — here’s where it tends to fit.

01

Adults 35-65 whose sleep, recovery, and energy have plateaued.

You’ve dialed in nutrition, training, and bloodwork basics. Your day-to-day recovery and sleep depth have quietly declined over a few years, and you want a physician-supervised next step.

02

Patients with documented age-related GH-axis decline.

If your provider has reviewed baseline labs (including IGF-1) and confirmed a decline consistent with age, a sermorelin-based protocol can be part of a longitudinal plan. Lab work is strongly recommended before starting.

03

People who want a single physician-led longevity protocol, not a stack of supplements.

One intake, one provider, one monthly shipment, one place to call. Both medications are compounded and prescribed under the same plan, so titration and follow-up are coordinated.

OPTML prescribes NAD+ and sermorelin only under clinical indications reviewed by a U.S.-licensed physician. We do not prescribe for athletic performance, bodybuilding, or aesthetic purposes. Compounded preparations are not FDA-approved.

Mechanism reference · scroll to see the shift

Watch the same six systems go from declining to restored.

Between ages 30 and 60, cellular NAD+ drops ~50% and the endogenous GH-axis pulse amplitude attenuates. Keep scrolling — watch the six systems the protocol is designed to address shift from red (age-related baseline) to green (mechanism target).

Cellular NAD+ availability NAD+ Restored
Mitochondrial ATP production NAD+ Supported
GH-axis pulse amplitude Sermorelin Reinforced
Slow-wave sleep depth Sermorelin Deeper
DNA-repair signaling (PARP / sirtuin) NAD+ Active
Lean-mass preservation signaling Sermorelin Supported

Mechanism reference. The six systems above describe targets the protocol is designed to address, drawn from published research on NAD+ co-factor availability (Verdin, Science, 2015; Yoshino, Cell Metab, 2018) and GHRH-axis support (Vitiello, Sleep, 2006; Khorram, JCEM, 1997). Compounded NAD+ and compounded sermorelin are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Not a prediction of personal outcomes. Individual response varies.

Peer-reviewed reference library

11 studies the protocol draws from.

Tap a topic to expand its peer-reviewed citations with direct PubMed links.

01NAD+ & cellular energy metabolism4 studies
  • Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science, 2015. PubMed 26785480 →
  • Yoshino J et al. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism, 2018. PubMed 29249689 →
  • Rajman L et al. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 2018. PubMed 29562503 →
  • Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol, 2016. PubMed 27552971 →
02NAD+, sirtuins & PARP-mediated DNA repair2 studies
  • Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 2014. PubMed 24786309 →
  • Sorrentino V et al. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity. Nature, 2017. PubMed 29211722 →
03Sermorelin & the endogenous GH-axis3 studies
  • Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Endocrine, 2006. PubMed 17075238 →
  • Khorram O et al. Effects of growth-hormone-releasing hormone on lean body mass and other clinical variables in older men and women. JCEM, 1997. PubMed 9112674 →
  • Murphy MG et al. MK-677, an orally active GHRH-mimetic, restores the GH/IGF-I axis in older adults. JCEM, 1998. PubMed 9482839 →
04GHRH-class compounds & slow-wave sleep1 study
  • Vitiello MV et al. Growth hormone-releasing hormone improves cognition and slow-wave sleep in older adults. Sleep, 2006. PubMed 16453978 →
05Age-related decline in the GH-axis1 study
  • Sinha I, Sinha-Hikim AP et al. Decline in growth hormone secretion with age and its consequences. JCEM, 2014 review. PubMed 25181281 →

All references are peer-reviewed and indexed on PubMed.gov. Educational reference only. Compounded preparations are not FDA-approved. The citations describe published research on NAD+ and GHRH-class compounds; they do not predict individual results.

How it works

Three steps. No insurance. No phone tag.

STEP 01

Complete the intake

A ~5-minute online assessment covering history, goals, current medications, and baseline lab access. You upload existing labs if you have them.

STEP 02

Physician review

A U.S.-licensed physician reviews your intake. They may order baseline labs (IGF-1, A1C, lipid panel, inflammatory markers) before approving a protocol. The Apex Panel covers all of these in one draw.

STEP 03

Monthly shipment

Both compounded medications, all supplies, and provider follow-up via call or message arrive together. Cancel, pause, or change cadence anytime from your patient portal.

Pricing

One price. Everything included.

Medication, physician oversight, supplies, and shipping all in. No insurance, no hidden fees, cancel anytime.

Monthly

$349/month

Billed monthly. Cancel anytime. HSA/FSA eligible.

Start monthly
Your monthly price includes everything. Both compounded medications, physician consultation, prescription, all supplies, and ongoing oversight. No hidden fees. No separate membership. Cancel anytime.

Real patients

What people on the protocol are saying.

Subjective patient experience reported in OPTML provider follow-ups. Not a medical efficacy claim. Individual response varies.

Recommended pairing

Start with a baseline.
The Apex Panel.

Most longevity protocols benefit from baseline labs — IGF-1, A1C, lipid markers, inflammatory markers, and more. The Apex Panel covers 160+ biomarkers across 12 organ systems in a single draw.

See the Apex Panel

0

biomarkers

12
Organ systems
1
Blood draw
$599
One-time

Questions

Frequently asked.

What is The Longevity Stack?

The Longevity Stack pairs two compounded protocols — subcutaneous NAD+ and sermorelin (a GHRH analog) — under one physician-led plan. The combination is intended to support cellular co-factor availability and the body’s own growth-hormone axis. Always reviewed and prescribed by a licensed U.S. physician. Compounded preparations are not FDA-approved.

Are NAD+ and sermorelin FDA-approved?

Compounded NAD+ and compounded sermorelin prepared for individual patient prescriptions are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Both compounded preparations dispensed through OPTML are prepared by FDA-registered 503A pharmacies under USP <797> sterility standards.

Who is this protocol prescribed for?

The Longevity Stack is reviewed by a U.S.-licensed physician for adults with documented age-related GH-axis decline and longevity-oriented goals. OPTML does not prescribe sermorelin or NAD+ for athletic performance, bodybuilding, or aesthetic purposes. Baseline labs are strongly recommended before starting.

Do I need lab work first?

Strongly recommended. Most patients on a longevity-oriented protocol benefit from a baseline panel including IGF-1, A1C, lipid markers, and inflammatory markers. The OPTML Apex Panel covers all of these (and many more) in one draw and is the most commonly paired baseline.

How much does it cost?

$349/month, billed monthly, cancel anytime. Or $999 every three months (a single quarterly shipment, save $48 vs paying monthly). Pricing is the same in every state OPTML serves. HSA/FSA eligible. No insurance is involved.

How is it shipped?

Both compounded medications, syringes, alcohol pads, and a sharps container arrive together via 2-3 day shipping. NAD+ ships in temperature-controlled packaging where required. Discreet packaging from our 503A pharmacy partners.

Can I cancel or pause?

Yes. Both monthly and 3-month plans can be canceled or paused anytime from your patient portal. No contracts. Refunds for unshipped medication are issued per OPTML’s standard policy.

Prescribed by board-certified U.S.-licensed clinicians

Licensed in all 50 states · Meet your care team